Key result
Upregulated NLRP3 inflammasome drives preeclampsia pathogenesis by interacting with endothelial dysfunction and microRNAs.
This narrative review explores the interconnected roles of endothelial dysfunction, NLRP3 inflammasome activation, and miRNA-mediated regulation in the pathogenesis of preeclampsia.
Should not yet change preeclampsia management; extends mechanistic insights into inflammatory pathways and highlights targets for future research.
Preeclampsia (PE) is a leading cause of maternal and perinatal complications and is classified by early or late onset according to the gestational age. The complex pathogenesis of PE involves placental ischemia, oxidative stress, angiogenic imbalance, and inflammation, all of which contribute to impaired placentation and widespread maternal endothelial dysfunction. These mechanisms drive hypertension, multi-organ involvement, and increased long-term cardiovascular risk. Parallel research highlighted the role of the NLRP3 inflammasome, a multiprotein complex that, upon activation, increases the gene expression, processing, and release of the pro-inflammatory cytokines IL-1β and IL-18. The NLRP3 pathway is markedly upregulated in placentas from pregnant women with PE, where endogenous danger signals stimulate inflammasome activation and amplify inflammation. Increasing evidence indicates that microRNAs (miRNAs) help regulate inflammatory processes, including the NLRP3 inflammasome, thereby affecting placental function and maternal adaptation. Although several immunoregulatory miRNAs may influence NLRP3 activity, their specific contribution to inflammasome regulation in PE remains insufficiently understood. Understanding these interactions could reveal new therapeutic targets for PE. In this narrative review, we explore the interconnected roles of endothelial dysfunction, inflammasome activation, and miRNA-mediated regulation in the pathogenesis of PE.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2026) studied this question. The NLRP3 inflammasome pathway is markedly upregulated in preeclampsia and interacts with endothelial dysfunction and microRNAs to drive disease pathogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: